Inventor · disambiguated record
Eva Bosse-Doenecke
Also filed as: BOSSE-DOENECKE EVA
5 granted patents·11 pending applications·12 citations·filing 2012–2023
70Inventor score
Top patents by PatentIndex Score
16 records- 0182US10858405B2EGFR binding proteinsNAVIGO PROTEINS GMBH·Filed 2016·Granted Dec 8, 2020·5 cites·10 claims
- 0275US9492572B2Dimeric binding proteins based on modified ubiquitinsNERKAMP JOERG·Filed 2012·Granted Nov 15, 2016·7 cites·21 claims
- 0367US12509493B2FOLR1 specific binding proteins for cancer diagnosis and treatmentNAVIGO PROTEINS GMBH·Filed 2019·Granted Dec 30, 2025·0 cites·14 claims
- 0462US2025388696A1Fusion proteins with half life extending domainsNAVIGO PROTEINS GMBH·Filed 2023·Application pending·0 cites
- 0556US12286458B2Binding proteins for the enzyme acid alpha glucosidase (GAA) and uses thereofNAVIGO PROTEINS GMBH·Filed 2020·Granted Apr 29, 2025·0 cites·15 claims
- 0652US2023272050A1Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus 2 (sars-cov-2)NAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 0752US2024117010A1Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus 2 (sars-cov-2)NAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 0848US2024209098A1Fusion proteins with specifity for type ii collagen and vegf-a for the treatment of eye diseasesNAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 0948US2023322946A1Serum stable binding proteins for human her2 for theranostic applicationsNAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 1047US2023416345A1New type ii collagen binding proteinsNAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 1147US2019292266A1Novel binding proteins comprising a ubiquitin mutein and antibodies or antibody fragmentsNAVIGO PROTEINS GMBH·Filed 2019·Application pending·0 cites
- 1244US2024218032A1Novel human programmed death ligand 1 (pd-l1) specific binding moleculesNAVIGO PROTEINS GMBH·Filed 2022·Application pending·0 cites
- 1343US2022168386A1Novel psma specific binding proteins for cancer diagnosis and treatmentNAVIGO PROTEINS GMBH·Filed 2020·Application pending·0 cites
- 1439US11414466B2Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancerNAVIGO PROTEINS GMBH·Filed 2018·Granted Aug 16, 2022·0 cites·10 claims
- 1538US2018030140A1Novel binding proteins comprising a ubiquitin mutein and antibodies or antibody fragmentsNAVIGO PROTEINS GMBH·Filed 2016·Application pending·0 cites
- 1629US2018273636A1Her2 binding proteins based on di-ubiquitin muteinsNAVIGO PROTEINS GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eva Bosse-Doenecke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →